TALPHERA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.021 USD | -1.87% |
|
-5.50% | +38.86% |
| 05-14 | Transcript : Talphera, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 17.67M | - | - | - | - | - | |
| 79.55B | ||||||
| 8.79B | ||||||
| 4.73B | - | - | ||||
| 3.92B | ||||||
| 2.28B |
- Stock Market
- Equities
- TLPH Stock
- Charts Talphera, Inc.
- Sector Chart
